MODERNA
Information

MODERNA

ISIN
US60770K1079
Ticker
MRNA
ISIN
US60770K1079
Ticker
MRNA
New Post

Information

stock large cap
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics.
Employees
1,300
Industries
Biotechnology & Drugs
Sector
Other

Community

Financials

52W Low
$93.79
52W High
$479.93
Market Capitalization
$142.89B
EBITDA
$7.77B
Beta
-99999.99

Analyst Ratings

Target Price
$304.92
This security is covered by 17 analysts
Buy
8
Hold
5
Sell
4

Activities

Trending